Analysis of Lung Adenocarcinoma Subtypes Based on Immune Signatures Identifies Clinical Implications for Cancer Therapy

Analysis of Lung Adenocarcinoma Subtypes Based on Immune Signatures Identifies Clinical Implications for Cancer Therapy

Lung cancer is the most common cause of cancer deaths worldwide, and lung adenocarcinoma (LUAD) is the most common histological subtype. However, the prognostic and predictive outcomes differ because of this cancer type heterogeneity. LUAD subtypes were identified on the basis of the immunogenomic p...

Full description

Bibliographic Details
Main Authors: Feng Xu, Jie-xin Chen, Xiong-bin Yang, Xin-bin Hong, Zi-xiong Li, Ling Lin, Yong-song Chen
Format: Article
Language:English
Published: Elsevier 2020-06-01
Series:Molecular Therapy: Oncolytics
Subjects:
immune signatures
immune response
lung adenocarcinoma
Online Access:http://www.sciencedirect.com/science/article/pii/S2372770520300462

Internet

http://www.sciencedirect.com/science/article/pii/S2372770520300462

Similar Items